Skip to Main Content

The Biotech Stock Mailbag has a new home. Here’s what readers are saying:

Steve N. writes, “I don’t understand why people are selling Clovis Oncology on this news of a partnership with Bristol-Myers Squibb? Can you explain what I am missing here?”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.